Pharmaceutical packaging plant
Wasdell Group opened its state-of-the-art pharmaceutical packaging plant in Dundalk, Ireland, in July 2019. Built with an estimated cost of €30m ($35.77m), the facility is Wasdell’s first plant outside the UK.
The new packaging facility enables Wasdell to serve customers in the European pharmaceutical industry. It carries out drug testing, production of primary and secondary packaging, and distribution in Europe and international markets. Backed by the Irish Government, the project generated 300 jobs.
The Dundalk facility received Manufacturer’s / Importation Authorisation (MIA) licence from the Health Products Regulatory Authority (HPRA) in July 2019.
The new packaging facility was built in the IDA Dundalk Science and Technology Park in Mullagharlin, Dundalk.
Its location has various transport connections for product shipment, being within one hour’s journey from Dublin and Belfast via the motorway. Furthermore, it is around a 70-minute journey from the site to Belfast City and Belfast International airports.
The site is also close to four deepwater ports located within a one-hour drive. It is also well-connected by rail links to Dublin and Belfast.
Irish plant has scope for future expansion with Phase I occupying 2.88ha. Wasdell holds land options to expand the site by another 2.68ha.
The site houses a 90,000ft2 packaging plant, including 11 production suites. It includes quality control (QC) import testing facilities, state-of-the-art packaging technologies, and storage and distribution facilities.
It also offers serialisation technology and customised manufacturing solutions, as well as temperature-controlled high-bay warehouses.
The Dundalk plant initially produces blister pack and container-filling packaging formats. It has the flexibility to offer alternative packaging types and dosage forms in the future.
Blister packaging offered by Wasdell includes polyvinyl chloride (PVC) / polyvinylidene chloride (PVDC), polyethylene terephthalate (PET), aclar, thermo-form, alu-alu (cold form), and peelable foil. Custom tooling and design are also offered under blister packaging services.
Wasdell offers a range of container-filling services for solid, liquid, and powder products. Filling of tablets, capsules, powders, and liquids in various containers are offered, along with labelling and label leaflets. Alternative packaging types available include strip packs, sachet filling, and packing.
The new plant also offers 2D data matrix printing and carton serialisation services to help pharmaceutical companies counter counterfeit and misbranded drugs. The technology applies 2D matrix barcodes on the product to ensure traceability.
Wasdell Group is a pharmaceutical services provider established in 1971 and based in England. It operates from Swindon, Burnley, and Newcastle, employing a total of 800 people.
The company offers technical, primary, and secondary packaging, manufacturing and distribution services to pharmaceutical and healthcare companies in Europe through its six divisions.
The Wasdell Packaging division offers primary and secondary packaging services, including manufacturing to support clinical trials and serialisation to address counterfeit products.
Cytiva opened a new facility for manufacturing Xcellerex XDR bioreactors in Shrewsbury, Massachusetts, US, in December 2020. The new manufacturing…
Lonza announced the expansion of its bioconjugation facility at its Visp site in Switzerland in December 2020. The expansion will…
Thermo Fisher Scientific is developing a new current good manufacturing practice (cGMP) facility in Carlsbad, California to expand its clinical…
KBI Biopharma is building a new commercial biologics manufacturing facility in the Research Triangle Park (RTP), Durham, in North Carolina,…